Close Menu

NEW YORK (GenomeWeb) – A seven-gene test for breast cancer risk could be cost-effective in improving life expectancy among women with a family history of disease, according to a new study from Quest Diagnostic researchers.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.